15 February 2011

BofA Merrill Lynch: Caterpillar - takeaways from 15th Annual India Investor Conf.

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Caterpillar India
  
Caterpillar - takeaways from 
15th Annual India Investor Conf. 
Our takeaways from the management meeting today at our 15th Annual
India Investor Conference in New Delhi
„Experience so far… in India - steady state continues
„ Revenue for facilities from India have been on the rise; Units manufactured in
Tiruvallur facility have increased manifold
„ Good distribution network with TIL and GMMCO
„ Moving beyond outsourcing, India is emerging as a manufacturing hub for CAT
Outlook for Caterpillar India
„ One of the “Big 8 Imperatives” for CAT is to “Win in China… grow to leadership in
India, Asean and CIS”
„ Rich Lavin’s presence in Hongkong as an Executive Officer member
„ Shift to Low Cost Producer model
„ Focus on products for Less Regulated Countries
„ Investments underway to the tune of US$200mn
Pointers for future success – in Indian market
„ Understand the Indian customer
„ Recognize diversity in regional markets
„ Localize the business
„ Embrace the local capacity to innovate
„ Don’t under-estimate local competition
„ Take the long term view

Morgan Stanley Research:: Buy Cox & Kings; target Rs 655

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Cox & Kings (COKI.BO, Rs395, OW, PT Rs655)
Why are we OW?
• C&K is well placed to capitalize on rising disposable
income in India and drive significant value accretion
through synergistic acquisitions.
• C&K’s international business complements its Indian
business, enabling scale, cross-selling of existing
products and for consolidated product sourcing.
• While many investors worry that C&K may destroy capital
through acquisitions, if the company is able to deploy its
cash at even half its current adjusted RoCE, the returns
thereon would nearly double profits, we estimate.

Morgan Stanley Research:: Buy Dabur India; target Rs115

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Dabur India (DABU.BO, Rs90.50, OW, PT Rs115)
Investment Thesis: Why OW
• Dabur seems to have carved out a niche for itself in the
herbal/natural/ayurvedic products space, which may not
be directly affected by increased competitive activity.
• Growth paradigm for cash cow categories seems to be
changing with a step up in growth in F11 which is not only
driving overall growth but also funding growth plans for
other categories.

Morgan Stanley Research:: Godrej Consumer, target Rs360

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Godrej Consumer Products (GOCP.BO, Rs346, EW, PT Rs360)
Investment Thesis: Why are we EW?
• Potential rise in competitive pressures in soaps segment.
• Potential sharp increase in input costs for soaps business.
• We expect a better entry opportunity as margins/market
share in the soaps business come under pressure and
the company consolidates its acquisitions.

Morgan Stanley Research:: Buy Nestlé India - target Rs 4,010

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Nestlé India (NEST.BO, Rs3216, OW, PT Rs4010)
Investment Thesis: Why OW
• Packaged foods (PF) category in India is at a nascent
stage. In our view, the category has the potential to grow
nearly 1000bp ahead of disposable growth in India
• Company is well placed to capitalize on the inflection point
in packaged foods consumption in India.
• Backed by international R&D in food technology from
parent company, which gives big competitive advantage
• Strong brands built over the years with great consumer
insights.
• Input cost inflation could constrain earnings in short term.

Macquarie Research:: The developed/developing reversal

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Global Economic Outlook
The developed/developing reversal
Event
 We revise our outlook for the global economy.
Impact
 Following a year of outperformance in 2010 in many emerging markets, the
focus for 2011 is likely to swing to developed economies, where a strong
recovery is taking hold.

Upgrade Marico: target Rs 115; Morgan Stanley Research,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Marico (MRCO.BO, Rs114, EW, PT Rs115)
Investment Thesis: Upgrade to EW
• We upgrade Marico to EW on recent stock
underperformance and higher than expected price
increase (~33%) in the core coconut oil portfolio.
• We continue to believe that the product life cycle for hair
oils in India may be close to its peak
• It will be a challenge for Marico to improve margins from
F2010 levels and maintain the organic growth momentum
seen during the last 10 years.
• Rising competitive threat from regional/local players.
• We await clarity on input cost (Copra) outlook and volume
trends following the sharp price increase to turn more
positive on the stock

Naukri JobSpeak index : Jan-11: The index moved up by 4% in Jan-11 as compared to Dec-10

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Jan-11: The index moved up by 4% in Jan-11 as compared to Dec-10.
Key Highlights
A positive hiring activity was witnessed across all top industry sectors, cities and functional areas.
IT and ITES sector witnessed strong hiring trends with the index moving up by 11% and 6% in Jan-11 as compared to Dec-10.
Delhi has been upbeat about hiring in Jan-11 with the index moving up by 9% as compared to the last month.
Demand for professionals in HR, Accounts and Sales moved up by 3% respectively in Jan-11 as compared to Dec-10.
On an overall level the index moved up by 20% in Jan-11 as compared to the same time a year ago.

UBS: US gasoline inventories reach 20-year high

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


UBS Investment Research
Asia Oil Explorer
US gasoline inventories reach 20-year high
􀂄 WTI crude prices fall on strong dollar
WTI crude oil prices fell 3.9%, ending last week at US$85.6/bbl, while Brent
prices rose 0.8%, ending last week at US$100.4/bbl. Easing concerns on a potential
disruption of oil supply from Suez Canal and a strong US dollar contributed to the
decline in WTI. According to the US Department of Energy (DOE) for the week
ended 04 February, crude inventories rose 1.9mbbls to 345.1mbbls versus Reuters’
consensus of a 2.4mbbls build. Gasoline inventories touched a 20-year high, rising
by 4.7mbbls to 240.9mbbls, their highest level since March 1990.

Macquarie Research, :: US aluminium orders surge in January

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


US aluminium orders surge in January
Feature article
 The latest North America aluminium orders data point to a surge in orders in
January. European orders are also reported to be solid, and physical premia
for aluminium remain very high in all developed regions. Overall the current
global aluminium market is in balance to small deficit, with China in significant
deficit at present, and as a result of the latter we retain our short term bullish
view on aluminium and alumina pricing.

Avoid Colgate-Palmolive India; target Rs 700::Morgan Stanley Research,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Colgate-Palmolive India (COLG.BO, Rs816, UW, PT Rs700)
Why are we downgrading to UW?
• We see a potential increase in competitive pressures.
• We believe the oral care segment has strong long-term
volume growth prospects in India because of its
under-penetration relative to other emerging markets. An
increase in competitive intensity, in this segment, is
inevitable, in our view.
• The market is underestimating the potential increase in
competition from HUL and Dabur, particularly in the low
price point segment. P&G also has the potential to enter
the oral care segment.
• Colgate might also start to experience cost inflation in
coming quarters as prices of key inputs have increased in
the past three months.
• A combination of higher comps for operating profit margins
and increased tax rate (expiry of tax breaks) will likely
constrain earnings progression, in our view.

Avoid Hindustan Unilever - target Rs 223:: Morgan Stanley Research,

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Hindustan Unilever (HLL.BO, Rs273, UW, PT Rs223)
Why are we UW?
• Earnings growth volatility in the next two to three quarters
is likely to put downside pressure on the stock.
• Potential increase in competitive pressures from P&G
likely to result in further stock de-rating.
• It would have to step up investments to gain market share
as competitive intensity is quite strong.
• Input cost pressures still remain at elevated levels.

FII DERIVATIVES STATISTICS FOR 15-Feb-2011

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


FII DERIVATIVES STATISTICS FOR 15-Feb-2011 
 BUYSELLOPEN INTEREST AT THE END OF THE DAY 
 No. of contractsAmt in CroresNo. of contractsAmt in CroresNo. of contractsAmt in Crores 
INDEX FUTURES613091673.28922802517.8458727016082.85-844.56
INDEX OPTIONS2951557991.212778977535.90206127356489.16455.31
STOCK FUTURES865042197.62706001781.03121577630038.15416.59
STOCK OPTIONS21655590.6321840594.4325832688.46-3.80
      Total23.54

 
 

Morgan Stanley Research:: Buy ITC, target Rs184

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


ITC (ITC.BO, Rs154, OW, PT Rs184)
Investment Thesis: Why OW
• Increased conviction in the company’s ability to manage
profitability even in an environment of sharp tax-driven
price hikes - correlation of ITC’s stock price to cigarette
volumes seems to be breaking down.
• Continuing structural improvement in non-cigarette
business profitability.
• We expect ITC’s dividend payout to increase.
• The stock is currently trading at 20.3x F12e vs. India
Consumer average of 22.4x F12e

UBS: Reliance Power 3Q FY11: Other income declined 42% YoY

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


UBS Investment Research
Reliance Power
3Q FY11: Other income declined 42% YoY
􀂄 Rs2.51bn of Sales and Rs1.44bn of PAT in 3Q FY11
In 3Q FY11, Reliance Power has reported Rs2.51bn of operating revenue and
Rs1.04bn (-42% YoY) of other income. The reported PAT is Rs1.44bn. The
company has been operating the first stage of Rosa (600MW) in this quarter.
Company’s depreciation charge was lower by Rs113mn in Q3 due to change in
depreciation accounting for Rosa Unit I from rates prescribed in Companies act to
rates notified by UPERC.

UBS: Reliance Infrastructure 3Q FY11: Operating performance In line; target Rs1,325

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

UBS Investment Research
Reliance Infrastructure
3Q FY11: Operating performance In line
�� In 3Q FY11, RELI has reported consolidated PAT of Rs4.1bn (+10% YoY)
Reliance Infra has reported consolidated results in this quarter. In 3Q FY11, RELI
reported consolidated sales of Rs37.44bn, up 14% YoY. The PAT at Rs4.1bn is up
10% YoY. For 9M FY11, PAT at Rs11.41bn is up 9% YoY. We believe that going
forward; the consolidated numbers would be a better reflection of the operations
considering the nature of RELI’s business.

UBS: Tata Power 3Q FY11: Good quarter

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


UBS Investment Research
Tata Power
3Q FY11: Good quarter
􀂄 3Q FY11: Consolidated Sales down 2% YoY, PAT up 412% YoY
In 3Q FY11, Tata Power’s consolidated sales fell 2% YoY to Rs44.4bn. The
reported PAT at Rs4.42bn is up 378% YoY. However, adjusted for forex gain of
Rs321m the recurring PAT is Rs4.1bn, up 412% YoY (+3% QoQ). In 9M FY11,
the recurring PAT is up 78% YoY to Rs12.7bn.

Morgan Stanley:: India Consumer 3QF11: Cost and Competitive Concerns to the Fore

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


India Consumer
3QF11: Cost and Competitive Concerns to the Fore

We maintain our cautious industry view… Despite a
13% fall in the FMCG index YTD, group average
valuations at 22.4x our one-year forward earnings
estimates are in line with long-term average multiples –
even as sustained competitive pressures threaten to
disturb market share equilibrium across categories.
…but see an underappreciated opportunity to invest
in select companies: We favor product categories
levered to disposable income growth. We are OW on
ITC, Nestle, United Spirits, Dabur and Cox & Kings.
• We reiterate our UW on HUL: Earnings growth
volatility, sustained cost pressures and rising
competitive pressures are likely to result in further
stock de-rating.
• We upgrade Marico to EW: This follows recent
underperformance and higher than expected price
increases in its coconut oil portfolio.
• We downgrade Colgate to UW: This reflects a
potential increase in competitive pressures.
• We believe GCPL will give a better entry
opportunity as margins and market share in the
soaps business come under pressure and the
company consolidates its acquisitions.
3QF11 Results – Quick Snapshot
• Overall, MS India consumer companies reported
revenue, operating profit and net profit growth of
16%, 1% and (-)2% as against our expectation of
20%, 10% and 8%, respectively.
• Domestic FMCG sales (ex ITC & Nestle) grew by
12% YoY.
• Gross margins contracted by 190bps (ex ITC and
Nestle), driving an operating margins decline of
230bps. Interestingly ad spends to sales
(ex-Colgate) declined by 10bps during the quarter.

Summary and Conclusions

Why Our Industry View Remains Cautious
• We believe EBITDA margins for home and
personal care (HPC) companies have peaked
near term.
• Input costs are up sharply, putting further
pressure on FMCG (fast-moving consumer
goods) companies in an already intensely
competitive environment. We expect further
erosion in HPC companies’ operating margins.
• We estimate operating margins for HPC
companies under our coverage will largely
remain flat in F12, after a 160bps fall in F2011.
• Contrary to general market perception, we
expect sustained competition – driven by
players with long-term commitments and strong
balance sheets.
• Even after a 13% fall in the FMCG index YTD,
group average valuations at 22.8x our one-year
forward earnings estimates are just in line with
the long-term average.
What’s Driving Our Price Target and Estimate
Changes (see detailed tables on pages 3-4).
3QF11 Results – Broad Overview
• MS India Consumer (ex ITC & Nestle)
average adjusted net profit declined 2.4%:
Overall, MS India Consumer (ex ITC & Nestle)
reported revenue, operating profit and net profit
growth of 16%, 1% and (-)2%. Our expectations
were 20%, 10% and 8%, respectively.
• Domestic FMCG sales (ex-ITC & Nestle)
grew by 12% YoY: Marico surprised positively;
we found GCPL’s growth disappointing.
• Gross margins contracted by 190bps (ex
ITC and Nestle) during the quarter: Our input
cost index has risen 11.3% YoY in 9MF11.
Palm oil prices rose a further 4% YTD.
• Operating margins declined by 230bps (ex
ITC and Nestle): This occurred even as the
average ratio of advertisement and promotional
expenses to sales (ex-Colgate) fell 10bps
during the quarter. In our view, promotions, in
response to rising input costs, were lower
during the quarter – yet ad spending still rose.
• Competition and cost pressure visible: Most
company commentaries mentioned lack of
reduction in competitive intensity and that
managing cost pressure was the key challenge.
All companies except Dabur and ITC reported a
decline in EBITDA margins.


Disconnect between Industry Fundamentals and Group Valuations
Intense Competition Is Proving Disruptive
In our view, EBITDA margins of HPC companies have
peaked near term: We estimate that operating margins for
HPC companies under our coverage will largely remain flat
in F12, after a 160bps fall in F2011. This driven by a
combination of continuing intense competition, increased
advertisement expenses and sharp increase in input costs.
Competition threatens to disturb market share equilibrium
across product categories: We observe three key forces –
the increase in advertising expenditure, the focus among
global FMCG companies on increasing their consumer base in
India, and the decrease in the price component of revenue
growth. See the following section for details.
Meanwhile, group valuations are still around the long-term
average: Part of the stocks’ recent fall can be explained by the
fall in consumer stocks in emerging economies. The MSCI AxJ
consumer index has underperformed the MSCI AxJ index by
11% over the past six months.
Downside risk to our/Street estimates: Moreover, if
competition and cost pressures intensify, our (and indeed
consensus) estimates of FMCG company earnings may prove
aggressive. We cite two reasons:
1) Sharp increase in input costs: Our proprietary input cost
index for domestic FMCG companies is up 11.3% YoY in
9MF11. At current prices, it is likely to be up 13.2% for
FY11e. Price increases continue to lag cost pressures, in
our view.
2) Persistent competitive activity: Our base case factors in
a relatively small, 10bps increase in advertising spending
in F12. If cost and competitive pressures intensity, our
expectations on ad spend for F12 may eventually prove to
be conservative.
Where We Could Be Wrong
1. Growth in the consumer staples market could accelerate,
accommodating new players, driven by strong rural gains
and an improved product mix: FMCG companies are
spending disproportionate resources not only to gain
market share but also to bolster existing categories and
develop new ones. If industry revenue growth
re-accelerates to 18-20%, new players could be
accommodated, softening the competitive environment.
2. Competitive intensity could dissipate as companies
become reconciled to existing market shares in their
respective segments: This is unlikely, in our view. Lead
indicators point towards a sharp increase in competitive
pressures. However, in an environment of rising input
costs, FMCG companies could choose to protect margins
and reduce competition.


We See Ongoing Competition Altering Market Equilibrium…
We see no evidence of diminishing intensity in competition in
the domestic FMCG industry. On the contrary, we expect
competition to alter market equilibrium across product
categories, fueled by three main sources.
Increase in Advertising Expenditure
The ratio of ad spending to sales remains above historical
levels, though it is down 10bps YoY (ex Colgate): In our
view, promotional expenses were lower in the last quarter, in
response to input cost pressures. Media spending still remains
at elevated levels. In quarterly commentary, most companies
maintained that this ratio should be higher for the FY – a good
predictor of continuing competitive activity in quarters to come.


The Impact of Global FMCG companies
Giants such as P&G are focusing on increasing their
consumer base in India: We expect Procter & Gamble to up
its planned investments in India. The global giant has signaled
renewed aggression in emerging economies; it will likely
introduce new products (at various price points) and new
categories. For instance, P&G has recently announced its
foray into the hair color market in India. In the recent Q2F11
earnings call, P&G global management reiterated their stated
plans to enter 12 new category country combinations, 40 new
category price tier combinations and 25 new category channel
combinations in the second half of FY11. The Indian business
was a strong performer for P&G in almost all categories, with
shampoo shipments +25%, Olay skincare more than doubling
YoY, Tide shipments +60% and value share in Laundry up
200bps YoY.


Price Component of Revenue Growth Has Decreased
Domestic revenue growth of FMGC companies accelerated to
12% in 3QF11 vs. 8% in 1HF11. Interestingly, the pricing
component remains negative despite easier comps. We
continue to believe that gaining volume market share is likely
to be the mantra of industry players over the next few
quarters.


…and with Input Costs Jumping, We See Margins Under Pressure
Sharp Increase in input costs amidst continuing
competitive intensity… Morgan Stanley’s Input Cost Index
(ICX) was up 11.3% in 9MF11 vs. 9MF10. Palm oil and copra
prices were up 24% and 34%, respectively.
• MS ICX for all consumer companies is now up between
9% and 35% YoY.
• For Q3F11 vs. Q3F10, input costs for Nestle rose the
least amongst our coverage (Nestle MS ICX +8.5%)…
• …while the input cost index for Marico increased the most
(Marico MS ICX +36%).
• HUL MS ICX (+10%), GCPL MS ICX (+25%), Colgate MS
ICX (+30%) & Dabur MS ICX (+13%) were also up yoy.


…which puts added pressure on the domestic FMCG
industry: If MS ICX remains unchanged at February 2011
levels, it is likely to be up 13.2% YoY in FY11e. Though some
companies have taken input-cost led price hikes in Q3 in
certain categories, we believe only a part of the overall cost
inflation has been passed on to the end-consumer.
• In terms of sensitivity, every 10% change in palm oil
prices affects HUL’s and GCPL’s operating profit margin
by ~80bps.
• Every 10% change in copra prices affects Marico’s
operating profit margin by ~200bps.


The Net Result – EBITDA Margins Likely to Narrow
We believe EBITDA margins for most FMCG companies
have peaked and will largely remain flat in F12: This
follows a 160bps decline in F11. If cost pressures are
sustained amidst intense competition, our and consensus
earnings estimates for FMCG companies may be too
aggressive. FMCG companies tend to reduce their advertising
and promotional expenses to control operating costs during
periods of input cost inflation. However, in the current
competitive environment, a sharp increase in input costs is
likely to erode margins.


Valuations: Exploring the Disconnect with Industry Fundamentals
Despite a 13% fall in the BSE FMCG index YTD, group
average valuations at 22.4x our one-year forward earnings
estimates are just about in line with the long-term average –
even as cost and competitive pressures threaten to disturb
market share equilibrium across categories.
Part of the stocks’ recent fall can be explained by the fall in
consumer stocks in emerging economies. The MSCI AxJ
consumer index has underperformed the MSCI AxJ index by
11% over the past six months.


We believe a heightened competitive environment could
manifest itself in a de-rating in stock valuations: We have
seen numerous examples of how stocks/industries have been
de-rated when competitive pressures are expected to rise,
including Hindustan Unilever’s sharp de-rating during the
laundry pricing war with P&G (2003-04) and Colgate’s during
the oral care marketing battle with HUL (1994-2001).


Highlights from F3Q11
• In F3Q11, the primary driver of revenue growth for
most companies and categories was higher volume.
Indian HPC firms continued to focus on increasing
market share. We believe this growth will slow over
the next few quarters as the price actions already
taken in some categories in order to mitigate input
cost pressures flow through.
• Domestic FMCG sales grew 15% in 3QF11 against
steady growth of 11% in 3QF10.
• The ratio of ad spending to sales for the industry
remains at historical highs despite declining yoy for
some companies. Ex-Colgate, ad spending was
down 10bps for the quarter.
• HUL and Marico disappointed with another quarter of
EBITDA decline.
• Marico has effected a 32-33% price increase in the
key Parachute CNO portfolio – volumes will likely
de-grow in 4Q
• GCPL’s international business (ex currency and
acquisition) disappointed. However, the international
businesses of Marico and Dabur continued to
perform strongly during the quarter, led by volume
growth.
• Colgate’s OPM declined by 800bps during the
quarter, driven by 630bps increase in ad spending.
Interestingly, ad spending in Q3F11 was the highest
since September 2001, the period when Colgate was
defending its market share against HUL
• Overall, FMCG companies reported results were
disappointing, in our view. Interestingly tax rate was
surprisingly low for all companies.














Macquarie Research, :: Earnings drivers and dividers- Breaking down the difference

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Microstrategy on MarQuee
Earnings drivers and dividers
Breaking down the difference
 We have examined the differences between the Macquarie analysts’
expectations and those of consensus earnings in Buy and Sell ideas on the
Macquarie MarQuee list.
Earnings growth upside to consensus and the market
 For the MarQuee buy ideas list, our conclusion is that for 2011, Macquarie
analysts expect an average of 16% in earnings growth versus just 8% with
consensus expectations and versus 12% for the MSCI Asia Ex index.
 Using the Earnings Analyser (chart below), we have identified that the key
difference between consensus and Macquarie analyst thinking in 2011 is the
expectations for margins (the black bars). While consensus expectations
suggest the MarQuee stocks will face margin compression similar to the
overall index in 2011, Macquarie analysts are forecasting that the MarQuee
stocks as a group will differentiate themselves and continue to expand
margins in 2011 – contributing an extra 4% to earnings growth.
 For the sell side of the list, the conclusion is almost a mirror – both Macquarie
and consensus expect these stocks to deliver lower growth than the index in
2011. The real differentiation for this group of stocks is 2012, where
consensus is expecting earnings to rebound, but Macquarie analysts project
that earnings growth will continue to remain muted.
Microstrategy bottom-up review supports our choices


FII & DII trading activity on NSE and BSE as on 15-Feb-2011

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


FII trading activity on NSE and BSE on Capital Market Segment
The following is combined FII trading data across NSE and BSE collated on the basis of trades executed by FIIs on 15-Feb-2011.
FII trading activity on NSE and BSE in Capital Market Segment(In Rs. Crores)
CategoryDateBuy ValueSell ValueNet Value
FII15-Feb-20112605.972372.92233.05

 
Domestic Institutional Investors trading activity on NSE and BSE on Capital Market Segment
The following is combined Domestic Institutional Investors trading data across NSE and BSE collated on the basis of trades executed by Banks, DFIs, Insurance, MFs and New Pension System on 15-Feb-2011.
DII trading activity on NSE and BSE in Capital Market Segment(In Rs. Crores)
CategoryDateBuy ValueSell ValueNet Value
DII15-Feb-2011881.31049.15-167.85
 

BSE, Bulk deals, 15/2/2011

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Scrip Code
Company
Client Name
Deal Type *
Quantity
Price **
590114
Arunjyoti Enterprises
PRECIOUS SECURITIES (P) LTD
B
40000
29.65
590114
Arunjyoti Enterprises
BP FINTRADE PRIVATE LIMITED
B
35947
29.32
590114
Arunjyoti Enterprises
P V RAVI KUMAR
S
40000
29.30
590114
Arunjyoti Enterprises
BP FINTRADE PRIVATE LIMITED
S
34948
29.71
530245
Aryaman Fin
MERCURY FUND MANAGEMENT COMPANY LIMITED
B
62000
24.40
530245
Aryaman Fin
ATULKUMAR J SHAH
B
175000
24.44

NSE, Bulk deals, 15-Feb-2011

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Symbol
Security Name
Client Name
Buy / Sell
Quantity Traded
Wght. Avg. 
Price
JUBLINDS
Jubilant Industries Ltd
SAMENA SPECIAL SITUATIONS MAURITIUS
BUY
78,794
202.43
KALINDEE
Kalindee Rail Nirman (Eng
SATYA PRAKASH CHAUDHARY HUF
BUY
74,613
138.36
KALINDEE
Kalindee Rail Nirman (Eng
SATYA PRAKASH CHAUDHARY HUF
SELL
74,613
138.61
OMKARCHEM
Omkar Spl Chem Ltd
ADROIT FINANCIAL SERVICES PRIVATE LIMITED
BUY
1,06,520
39.96
OMKARCHEM
Omkar Spl Chem Ltd
ADROIT FINANCIAL SERVICES PRIVATE LIMITED
SELL
1,06,520
40.03
OMKARCHEM
Omkar Spl Chem Ltd
CREDIT SUISSE (SINGAPORE) LIMITED A/C CREDIT SUISSE (SINGAP
SELL
1,44,700
40.06
RELMEDIA
Reliance MediaWorks Ltd
ELEPHANTA SHARE TRADING PRIVATE LIMITED
BUY
2,55,039
153.62
RELMEDIA
Reliance MediaWorks Ltd
ELEPHANTA SHARE TRADING PRIVATE LIMITED
SELL
2,55,039
153.76
RELMEDIA
Reliance MediaWorks Ltd
GENUINE STOCK BROKERS PVT LTD
BUY
3,05,052
159.30
RELMEDIA
Reliance MediaWorks Ltd
GENUINE STOCK BROKERS PVT LTD
SELL
3,05,052
159.43
RKDL
Ravi Kumar Distilleries
PREFER ABSAN PRIVATE LIMITED
BUY
1,65,000
28.90
TALWALKARS
Talwalkar Fitness Ltd
PRUSIK ASIA FUND PUBLIC LIMITED COMPANY
SELL
1,84,893
200.15
XLENERGY
XL Energy Limited
GOLDMAN SACHS INVESTMENTS MAURITIUS I LTD
SELL
1,21,510
16.03